Multifactorial stroma-mediated resistance is a major contributor to residual disease under targeted therapies in lung cancers.
多因素基质介导的耐药性是肺癌靶向治疗后残留病灶的主要原因
期刊:
影响因子:
doi:10.21203/rs.3.rs-6264377/v1
Desai Bina, Miti Tatiana, Prabhakaran Sandhya, Miroshnychenko Daria, Henry Menkara, Marusyk Viktoriya, Kumar Pragya, Ozakinci Hilal, Gatenbee Chandler, Bui Marilyn, Boyle Theresa A, Scott Jacob, Altrock Philipp M, Haura Eric, Anderson Alexander R A, Basanta David, Marusyk Andriy